Filing Details
- Accession Number:
- 0001127602-14-018557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-22 18:05:22
- Reporting Period:
- 2014-05-20
- Filing Date:
- 2014-05-22
- Accepted Time:
- 2014-05-22 18:05:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376548 | Elliot Ehrich | 852 Winter St. Waltham MA 02451 | Svp, R&D & Cmo, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-05-20 | 3,750 | $0.00 | 24,742 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-05-20 | 1,769 | $43.98 | 22,973 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2014-05-21 | 1,981 | $44.00 | 20,992 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2014-05-21 | 4,500 | $0.00 | 25,492 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-05-21 | 2,122 | $44.48 | 23,370 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Unit Award | Disposition | 2014-05-20 | 3,750 | $0.00 | 3,750 | $0.00 |
| Ordinary Shares | Restricted Stock Unit Award | Disposition | 2014-05-21 | 4,500 | $0.00 | 4,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,750 | 2012-05-20 | No | 4 | M | Direct | |
| 9,000 | 2013-05-21 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.75 to $44.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 5/20/12.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 5/21/13.
Billionaire Hedge Funds
